Pfizer-BioNTech Covid-19 vaccine remains highly effective after 6 months, trial data show
WASHINGTON, April 2 — The ongoing phase three clinical trial of Pfizer-BioNTech’s Covid-19 vaccine showed its protection remains high for up to six months after...